Benfotiamine blocks three major pathways of hyperglycemic damage and prevents experimental diabetic retinopathy

[1]  R. Duggleby,et al.  Properties and functions of the thiamin diphosphate dependent enzyme transketolase. , 1998, The international journal of biochemistry & cell biology.

[2]  H. Saito,et al.  CD18/ICAM-1-dependent oxidative NF-kappaB activation leading to nitric oxide production in rat Kupffer cells cocultured with syngeneic hepatoma cells. , 1997, The Journal of clinical investigation.

[3]  H. Hammes,et al.  Efficacy of benfotiamine versus thiamine on function and glycation products of peripheral nerves in diabetic rats , 2001, Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association.

[4]  H. Hammes,et al.  Acceleration of experimental diabetic retinopathy in the rat by omega-3 fatty acids , 1996, Diabetologia.

[5]  G. King,et al.  Amelioration of accelerated diabetic mesangial expansion by treatment with a PKC β inhibitor in diabetic db/db mice, a rodent model for type 2 diabetes , 2000, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[6]  Z. Makita,et al.  Progression of Nephropathy in Spontaneous Diabetic Rats Is Prevented by OPB-9195, a Novel Inhibitor of Advanced Glycation , 1997, Diabetes.

[7]  S. Bursell,et al.  Amelioration of Vascular Dysfunctions in Diabetic Rats by an Oral PKC β Inhibitor , 1996, Science.

[8]  M. Andrassy,et al.  Diabetes-associated sustained activation of the transcription factor nuclear factor-kappaB. , 2001, Diabetes.

[9]  L. Rossetti,et al.  Skeletal muscle glycogenolysis is more sensitive to insulin than is glucose transport/phosphorylation. Relation to the insulin-mediated inhibition of hepatic glucose production. , 1993, The Journal of clinical investigation.

[10]  D. Loew.  Pharmacokinetics of thiamine derivatives especially of benfotiamine. , 1996, International journal of clinical pharmacology and therapeutics.

[11]  I. G. Fantus,et al.  Hyperglycemia-induced mitochondrial superoxide overproduction activates the hexosamine pathway and induces plasminogen activator inhibitor-1 expression by increasing Sp1 glycosylation. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[12]  Riaz-ul-Haq,et al.  Activation of nuclear factor-kappaB in cultured endothelial cells by increased glucose concentration: prevention by calphostin C. , 1997, Journal of cardiovascular pharmacology.

[13]  A. Schmidt,et al.  Suppression of accelerated diabetic atherosclerosis by the soluble receptor for advanced glycation endproducts , 1998, Nature Medicine.

[14]  D. Grüneklee,et al.  Bioavailability assessment of the lipophilic benfotiamine as compared to a water-soluble thiamin derivative. , 1991, Annals of nutrition & metabolism.

[15]  M. Brownlee.  Biochemistry and molecular cell biology of diabetic complications , 2001, Nature.

[16]  D. Moller,et al.  Differential Regulation of Glucose Transport and Transporters by Glucose in Vascular Endothelial and Smooth Muscle Cells , 1993, Diabetes.

[17]  M. Kimura,et al.  Blood thiamine levels in outpatients with diabetes mellitus. , 1987, Journal of nutritional science and vitaminology.

[18]  G. Jerums,et al.  Retardation by Aminoguanidine of Development of Albuminuria, Mesangial Expansion, and Tissue Fluorescence in Streptozocin-Induced Diabetic Rat , 1991, Diabetes.

[19]  R. Holman,et al.  Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. , 1998 .

[20]  Paul J Thornalley,et al.  Suppression of the accumulation of triosephosphates and increased formation of methylglyoxal in human red blood cells during hyperglycaemia by thiamine in vitro. , 2001, Journal of biochemistry.

[21]  Paul J Thornalley,et al.  Overexpression of glyoxalase-I in bovine endothelial cells inhibits intracellular advanced glycation endproduct formation and prevents hyperglycemia-induced increases in macromolecular endocytosis. , 1998, The Journal of clinical investigation.

[22]  V. J. Stevens,et al.  Nonenzymatic glycosylation of hemoglobin. , 1977, The Journal of biological chemistry.

[23]  Y. Kaneda,et al.  Normalizing mitochondrial superoxide production blocks three pathways of hyperglycaemic damage , 2000, Nature.

[24]  M. Porta,et al.  Thiamine corrects delayed replication and decreases production of lactate and advanced glycation end-products in bovine retinal and human umbilical vein endothelial cells cultured under high glucose conditions , 1996, Diabetologia.

[25]  S. Haffner,et al.  Effects of Diabetes and Level of Glycemia on All-Cause and Cardiovascular Mortality: The San Antonio Heart Study , 1998, Diabetes Care.

[26]  S. Genuth,et al.  The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. , 1993, The New England journal of medicine.

[27]  Uk-Prospective-Diabetes-Study-Group.  Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33) , 1998, The Lancet.

[28]  H. Hammes,et al.  Antioxidant treatment of experimental diabetic retinopathy in rats with nicanartine , 1997, Diabetologia.

[29]  T. Jacob,et al.  Thiamine reverses hyperglycemia-induced dysfunction in cultured endothelial cells. , 2001, Surgery.

[30]  S. Maskevich,et al.  Thiamine oxidative transformations catalyzed by copper ions and ascorbic acid. , 1997, Biochemistry. Biokhimiia.

[31]  H. Hammes,et al.  Aminoguanidine treatment inhibits the development of experimental diabetic retinopathy , 1991, Proceedings of the National Academy of Sciences of the United States of America.